By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TRACON Pharmaceuticals, Inc. 

4510 Executive Drive
Suite 330
San Diego  California  92121  U.S.A.
Phone: 858-550-0780 Fax: 858-550-0786


SEARCH JOBS


Industry
Biotechnology






Company News
TRACON Pharmaceuticals, Inc. Appoints William Larue To Its Board Of Directors 8/4/2014 9:01:57 AM
Santen Pharmaceutical And TRACON Pharmaceuticals, Inc. Announce Agreement For The Development And Commercialization Of TRC105 In Ophthalmology 3/4/2014 11:38:33 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study Of TRC105 In Patients With Advanced Soft Tissue Sarcoma 2/4/2014 9:27:32 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study of TRC105 in Patients With Metastatic Renal Cell Carcinoma 9/24/2013 9:22:24 AM
TRACON Pharmaceuticals, Inc. Announces TRC105 Clinical Trials, Abstract Presentations at 2013 American Society of Clinical Oncology Annual Meeting 5/20/2013 6:47:46 AM
TRACON Pharmaceuticals, Inc. Announces Appointment of Kenneth Galbraith as Chairman of the Board 12/6/2011 10:07:42 AM
TRACON Pharmaceuticals, Inc. Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development 4/20/2011 6:50:10 AM
TRACON Pharmaceuticals, Inc. Announces Upcoming Scientific Presentations on Clinical-Stage Cancer Therapeutics TRC105 and TRC102 10/25/2010 9:15:56 AM
TRACON Pharmaceuticals, Inc. to Present Three First-in-Class Oncology Therapeutics (TRC105, TRC102, and TRC093) at the American Society of Clinical Oncology 2010 Annual Meeting 5/19/2010 8:30:54 AM
TRACON Pharmaceuticals, Inc. Announces Start of Phase 1/2 Trial of TRC105 Antibody Therapy for Prostate Cancer 4/26/2010 9:00:53 AM
123
//-->